Last reviewed · How we verify

NCT05607524

Effects of Probiotic Capsules in Promoting Fat Excretion by Human Trial

Status unknown NA Last updated 7 November 2022
What this trial tests

NA trial testing probiotics in Obesity in 60 participants. Status unknown.

Timeline
29 September 2022
Primary endpoint
29 December 2022
16 January 2023

Quick facts

Lead sponsorChung Shan Medical University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeprevention
Enrollment60
Start date29 September 2022
Primary completion29 December 2022
Estimated completion16 January 2023
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Chung Shan Medical University

Who can join

Adults 20 to 40, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to evaluate the efficacy of 2 capsules (500 mg per capsule, 1000 mg per day) of Grape King Probiotic Capsules per day in promoting fat excretion in obese patients by clinical human food test.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of probiotics

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Chung Shan Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05607524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing